The only Catch22 is that if they frightened off all the people with real ME and only studied people without ME then they did't even prove the treatments did not work in ME because they did not study it. It takes quite a stretch to see why they should work in real ME but there is a hint of cherry-picking about saying they nailed the disproof when the methodology was so bad it could not disprove anything much!
There is so much we still don't know about this trial because of the way it was done and what was and was not measured.
I've never thought it safe to make any assumptions about the participants though. We simply don't know how many of participants had "real" ME.
Bad criteria are more likely to include such patients than exclude them. (They should have excluded them if, as Sharpe is so keen to say, they weren't studying ME. But I'm not sure how they could have done that.)
The whole "if you showed improvement, you can't have had ME" thing is unfair to those who reported subjective improvement despite being in the trial - no-one benefits from pretending they had an improvement when they didn't, but that's what they were being asked to do.
And we *still* don't know how much daily exercise/activity anyone actually did, because they didn't record it. Not even the patient/clinician-set goals were recorded in the main dataset because it would have clearly shown which intervention they were receiving (which is another flaw of the trial).
For every flaw, there will be a whole gamut of contradictory statements given by the trial authors. According to White, GET is not harmful, because it was done really, really carefully, unlike in the usual fatigue clinic setting. Yet Wessely describes it as a "pragmatic trial".
As
@Michiel Tack says, the only thing you can take away from all this is that CBT/GET don't work. Not in ME. Not in CFS. Not in any fatigue-related illness.